Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2015-06-24 Tx date 2015-06-22 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Stolz, Brian Matheison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,022,198
+4,389 vol $232.90 each |
103,178 | |
Filed 2015-06-24 Tx date 2015-06-22 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Stolz, Brian Matheison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-533,806.80
-2,292 vol $232.90 each |
100,886 | |
Filed 2015-06-24 Tx date 2015-06-22 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Stolz, Brian Matheison
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
$-1,022,198.10
-4,389 vol $232.90 each |
29,044 | |
Filed 2015-05-05 Tx date 2014-12-23 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Stolz, Brian Matheison
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
$-2,142,263.10
-15,242 vol $140.55 each |
||
Filed 2015-05-05 Tx date 2015-05-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Stolz, Brian Matheison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$819,598
+3,675 vol $223.02 each |
100,710 | |
Filed 2015-05-05 Tx date 2015-05-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Stolz, Brian Matheison
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
$-819,598.50
-3,675 vol $223.02 each |
33,433 | |
Filed 2015-05-05 Tx date 2014-12-23 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Stolz, Brian Matheison
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
$-1,625,741.85
-11,567 vol $140.55 each |
44,458 | |
Filed 2015-05-05 Tx date 2015-05-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Stolz, Brian Matheison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-428,421.42
-1,921 vol $223.02 each |
98,789 | |
Filed 2015-05-05 Tx date 2014-12-23 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Stolz, Brian Matheison
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
$-2,168,124.30
-15,426 vol $140.55 each |